Sofinnova Investments, Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$32,879,143
-42.4%
322,471
-48.6%
2.15%
-41.0%
Q1 2023$57,068,938
+51.4%
627,683
-36.7%
3.65%
+63.2%
Q4 2022$37,687,182
+83.2%
992,029
+21.2%
2.24%
+86.8%
Q3 2022$20,566,000
-13.7%
818,376
+4.4%
1.20%
-39.7%
Q2 2022$23,821,000
+20.7%
783,851
+30.1%
1.98%
+32.4%
Q1 2022$19,739,000
+24.6%
602,545
+282.6%
1.50%
+59.7%
Q3 2021$15,845,000
+40.6%
157,488
+97.8%
0.94%
+44.5%
Q2 2021$11,266,000
-52.6%
79,601
-66.6%
0.65%
-54.6%
Q1 2021$23,780,000
+29.2%
238,520
+60.1%
1.43%
+30.5%
Q4 2020$18,412,000
+175.4%
148,937
+117.1%
1.10%
+121.0%
Q3 2020$6,685,000
+228.7%
68,615
+426.4%
0.50%
+287.5%
Q2 2020$2,034,000
-83.0%
13,035
-91.2%
0.13%
-88.1%
Q3 2019$11,936,000
+9.5%
148,669
+28.7%
1.08%
+7.7%
Q2 2019$10,901,000
+96.1%
115,536
+77.7%
1.00%
+86.9%
Q1 2019$5,559,000
-37.3%
65,031
-58.8%
0.54%
-51.4%
Q4 2018$8,863,000
+155.5%
157,984
+59.2%
1.10%
+399.5%
Q2 2018$3,469,000
+475.3%
99,216
+237.7%
0.22%
+112.5%
Q1 2018$603,00029,3830.10%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders